IGHE and Alzheimer disease: Similar to topical administration, oral MQL administration ameliorated AD symptoms such as ear swelling and infiltration of inflammatory cells in ear (Figure 6H–J), and TMA-induced serum IgE production was decreased in the MQL-administered group compared with that in the sham group (Figure 6K).